| |  Online-Ressource |
|---|
| Verfasst von: | Fan, Ziwen [VerfasserIn]  |
|---|
| | Edelmann, Dominic [VerfasserIn] |
|---|
| | Yuan, Tanwei [VerfasserIn] |
|---|
| | Köhler, Bruno Christian [VerfasserIn] |
|---|
| | Hoffmeister, Michael [VerfasserIn] |
|---|
| | Brenner, Hermann [VerfasserIn] |
|---|
| Titel: | Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood |
|---|
| Verf.angabe: | Ziwen Fan, Dominic Edelmann, Tanwei Yuan, Bruno Christian Köhler, Michael Hoffmeister & Hermann Brenner |
|---|
| E-Jahr: | 2024 |
|---|
| Jahr: | 06 September 2024 |
|---|
| Umfang: | 9 S. |
|---|
| Illustrationen: | Illustrationen |
|---|
| Fussnoten: | Gesehen am 24.02.2025 |
|---|
| Titel Quelle: | Enthalten in: npj precision oncology |
|---|
| Ort Quelle: | [London] : Springer Nature, 2017 |
|---|
| Jahr Quelle: | 2024 |
|---|
| Band/Heft Quelle: | 8(2024), Artikel-ID 191, Seite 1-9 |
|---|
| ISSN Quelle: | 2397-768X |
|---|
| Abstract: | While genome-wide association studies are valuable in identifying CRC survival predictors, the benefit of adding blood DNA methylation (blood-DNAm) to clinical features, including the TNM system, remains unclear. In a multi-site population-based patient cohort study of 2116 CRC patients with baseline blood-DNAm, we analyzed survival predictions using eXtreme Gradient Boosting with a 5-fold nested leave-sites-out cross-validation across four groups: traditional and comprehensive clinical features, blood-DNAm, and their combination. Model performance was assessed using time-dependent ROC curves and calibrations. During a median follow-up of 10.3 years, 1166 patients died. Although blood-DNAm-based predictive signatures achieved moderate performances, predictive signatures based on clinical features outperformed blood-DNAm signatures. The inclusion of blood-DNAm did not improve survival prediction over clinical features. M1 stage, age at blood collection, and N2 stage were the top contributors. Despite some prognostic value, incorporating blood DNA methylation did not enhance survival prediction of CRC patients beyond clinical features. |
|---|
| DOI: | doi:10.1038/s41698-024-00689-5 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1038/s41698-024-00689-5 |
|---|
| | kostenfrei: Volltext: https://www.nature.com/articles/s41698-024-00689-5 |
|---|
| | DOI: https://doi.org/10.1038/s41698-024-00689-5 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Cancer epigenetics |
|---|
| | Colorectal cancer |
|---|
| | Prognostic markers |
|---|
| K10plus-PPN: | 1917882033 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood / Fan, Ziwen [VerfasserIn]; 06 September 2024 (Online-Ressource)
